These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1709694)

  • 1. Expression of processed core protein of hepatitis C virus in mammalian cells.
    Harada S; Watanabe Y; Takeuchi K; Suzuki T; Katayama T; Takebe Y; Saito I; Miyamura T
    J Virol; 1991 Jun; 65(6):3015-21. PubMed ID: 1709694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma.
    Watanabe Y; Harada S; Saito I; Miyamura T
    Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus.
    Chiba J; Ohba H; Matsuura Y; Watanabe Y; Katayama T; Kikuchi S; Saito I; Miyamura T
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4641-5. PubMed ID: 1905012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen.
    Katayama T; Mazda T; Kikuchi S; Harada S; Matsuura Y; Chiba J; Ohba H; Saito I; Miyamura T
    Hepatology; 1992 Mar; 15(3):391-4. PubMed ID: 1371981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of the antibody to the putative core protein of hepatitis C virus in patients with chronic liver disease.
    Manzini P; Calvo PL; Brunetto MR; Baldi M; Abate ML; Oliveri F; Negro F; Balzola F; Saracco G; Verme G
    Liver; 1993 Aug; 13(4):222-6. PubMed ID: 7690874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression in E. coli and purification of a chimeric p22-NS3 recombinant antigen of hepatitis C virus (HCV).
    Osborne S; Cecconato E; Griva S; Garetto F; Calogero R; Rosa C; Bonelli F
    FEBS Lett; 1993 Jun; 324(3):253-7. PubMed ID: 8405360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive core peptides of hepatitis C virus produced in Escherichia coli and in vitro DNA amplification-restricted transcription-translation system.
    Esumi M; Hayashi N; Takahashi H; Shikata T; Moriyama M; Arakawa Y; Eto T; Nishihara T; Nozaki C; Mizuno K
    J Virol Methods; 1996 May; 59(1-2):91-8. PubMed ID: 8793834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunodominant regions of core protein of hepatitis C virus and antibody-assays employing two recombinant core proteins, p22 and JCC4].
    Ohba H; Chiba J; Miyamura T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):212-23. PubMed ID: 7563702
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases.
    Inoue Y; Suzuki R; Matsuura Y; Harada S; Chiba J; Watanabe Y; Saito I; Miyamura T
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():2151-4. PubMed ID: 1379627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications.
    Chen PJ; Hwang LH; Chang LY; Kao JH; Chen DS
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():67-70. PubMed ID: 7689510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
    Chien DY; Choo QL; Tabrizi A; Kuo C; McFarland J; Berger K; Lee C; Shuster JR; Nguyen T; Moyer DL
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10011-5. PubMed ID: 1279666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
    Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
    Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to hepatitis C virus and hepatitis C virus infection.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Fusamoto H; Kamada T
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():76-9. PubMed ID: 7689512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid.
    Major ME; Vitvitski L; Mink MA; Schleef M; Whalen RG; Trépo C; Inchauspé G
    J Virol; 1995 Sep; 69(9):5798-805. PubMed ID: 7637024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein.
    Zhang ZX; Chen M; Wallhagen K; Trojnar J; Magnius LO; Wahren B; Sällberg M
    Clin Exp Immunol; 1994 Jun; 96(3):403-9. PubMed ID: 7516270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
    Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
    J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of the antibody against core protein of hepatitis C virus.
    Ohkoshi S; Watanabe M; Kuwana K; Tawaraya H; Kamimura T; Asakura H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():80-3. PubMed ID: 7689513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells.
    Matsuura Y; Harada S; Suzuki R; Watanabe Y; Inoue Y; Saito I; Miyamura T
    J Virol; 1992 Mar; 66(3):1425-31. PubMed ID: 1310756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of the immunodominant regions of hepatitis C virus type III and IV by immunoscreening.
    Sato A; Kazami J; Arima T; Nakamura H; Kunitomo T
    Acta Virol; 1993; 37(2-3):132-42. PubMed ID: 7692715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.